NCT04224480 2024-01-19
Longitudinal Immune-phenotyping of HCC Following MK-3475
National Cancer Centre, Singapore
Phase 1 Unknown
Clinical Trials
5 trialsNCT03099564 2023-02-06
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
Hoosier Cancer Research Network
Phase EARLY_PHASE1 Unknown
NCT05339581 2022-04-27
iPLENTY-pvtt
RenJi Hospital
Phase NA Unknown
NCT05233358 2022-02-10
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure
The Central Hospital of Lishui City
Phase NA Unknown
NCT03337841 2017-11-09
Pembrolizumab as Neoadjuvant Treatment in HCC
Kindai University
Phase 2 Unknown